Rakuten Medical Reshapes Leadership with New CEO Appointment

Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox platform-based photoimmunotherapy, announced that Hiroshi "Mickey" Mikitani will transition from Chief Executive Officer (CEO) to Executive Chairman of the Board, and President Minami Maeda will become the next CEO, effective on July 1, 2026.

As Rakuten Medical enters its next phase of growth, this leadership transition reflects the company's ongoing evolution and commitment to its corporate mission of "Conquering Cancer." The move aims to accelerate decision-making and strengthen disciplined execution across the organization.

As Executive Chairman, Mickey will continue to provide strategic direction and long-term vision while remaining deeply committed to the company's mission, supporting long-term growth initiatives.

As the full-time, dedicated CEO, Minami will work closely with the global team to drive agile decision-making, while strengthening organizational resilience and execution in preparation for upcoming regulatory approval and commercial launch in the United States and other markets.